Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries
Based on these findings, one of the most important next steps for improving the effectiveness and transparency of national procurement is for procurement agencies to publish detailed quality selection criteria and an up-to-date list of the medical products they have purchased, with key product information. We hope these findings can help inform the conversation about implementing and enforcing best practices at the regulatory-procurement interface, with the goal of improving access to quality versions of medical products in Africa and globally.
Authors
- Murray Lumpkin (ORCID: https://orcid.org/0000-0002-8708-7617)
- Kristin N. Harper (ORCID: https://orcid.org/0000-0002-5181-1263)
- Charles Preston (ORCID: https://orcid.org/0000-0003-1891-2254)
- David Mukanga (ORCID: https://orcid.org/0000-0001-5554-7466)
- Anna Wong (ORCID: https://orcid.org/0000-0001-8163-4088)
- Bonface Fundafunda
- Chimwemwe Chamdimba (ORCID: https://orcid.org/0000-0002-9016-4193)
- Mariangela Castro-Arteaga
- Jillian C. Kohler
- Saher Panjwani
- Anthony B. Kapeta
Institutions
- Western University (CA)
- Gates Foundation (US)
- University of Toronto (CA)
- Culture Resource (EG)
- Public Health Ontario (CA)
- Care Resource (US)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1080/20523211.2024.2436898
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation